Search Results for 'engl med'

engl med published presentations and documents on DocSlides.

Novel antithrombotic agents in acute coronary syndromes: be
Novel antithrombotic agents in acute coronary syndromes: be
by jane-oiler
n . P2Y12 inhibitors. Giuseppe Biondi Zoccai. Sap...
Prevention of Coronary Heart Disease with Pravastatin in Me
Prevention of Coronary Heart Disease with Pravastatin in Me
by sherrill-nordquist
James Shepherd, M.D., Stuart M. Cobbe, M.D., Ian ...
A multicenter, randomized, double-blind, parallel-group, ac
A multicenter, randomized, double-blind, parallel-group, ac
by liane-varnes
PARADIGM-HF Study . Prospective comparison of ARN...
Anticoagulation and Thrombosis Management
Anticoagulation and Thrombosis Management
by pasty-toler
Anticoagulation and Thrombosis Management A Revie...
Focused Critical Care Review
Focused Critical Care Review
by erica
. 2017. February 2, 2018. Renee Hebbeler-Clark, MD...
Overview of the ISCHEMIA Trial Results
Overview of the ISCHEMIA Trial Results
by summer
Gregg W. Stone, MD. The Zena and Michael A. Wiener...
Updates In Management of Hematological
Updates In Management of Hematological
by StarDust
Malignancies. Abhinav Deol, MD. Professor of Oncol...
n engl j med wwwnejmorgmarch environmental modifiers such as weight
n engl j med wwwnejmorgmarch environmental modifiers such as weight
by eliza
in a blood body-mass grounds (including black, Ca...
Cangrelor : Friend or Foe? -
Cangrelor : Friend or Foe? -
by ariel
Cangrelor. : Not the CHAMPION We Hoped For. James ...
Molnupiravir  for Oral  Treatment
Molnupiravir for Oral Treatment
by blanko
of Covid-19 in . Nonhospitalized. Patients. . Ja...
Empagliflozin  in  Heart
Empagliflozin in Heart
by brooke
. Failure. . with. a . Preserved. Ejection Frac...
Reversing Course:  Managing Anticoagulation and Antiplatelet Bleeding
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
by kyle585
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in
3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in
by yoshiko-marsland
TURQUOISE-II. Phase 3. . Treatment. Naïve and ...
Original Article
Original Article
by myesha-ticknor
. A Randomized Trial of Intensive versus Standar...
YIR On  Demand Lung Benjamin Levy, MD 
YIR On Demand Lung Benjamin Levy, MD 
by jovita
Assistant Professor. Johns Hopkins School of Medic...
Sglt2 inhibitor Dr.  NOUSHIN-KHALILI
Sglt2 inhibitor Dr. NOUSHIN-KHALILI
by roxanne
ENDOCRINOLOGIST. 97.12.7. Diabetes Prevalence in I...
Lenacapavir  for Persons with Multidrug-Resistant HIV
Lenacapavir for Persons with Multidrug-Resistant HIV
by elise
CAPELLA. Lenacapavir. in Multidrug Resistant HIV....
Surviving Sepsis Campaign
Surviving Sepsis Campaign
by alida-meadow
Guidelines . for Management of Severe Sepsis and ...
A NEW ERA in IPF:
A NEW ERA in IPF:
by pamella-moone
Trials and Treatments. Craig Thurm, MD. Director,...
Heart Failure Management
Heart Failure Management
by faustina-dinatale
(2013 Updated Guidelines). Blake Wachter, MD, PhD...
Why LAMA is Fundamental Treatment
Why LAMA is Fundamental Treatment
by test
for COPD. . ?. GPM-SV-0004-ID . Suradi, . Santi....
A NEW ERA in IPF: Trials and Treatments
A NEW ERA in IPF: Trials and Treatments
by celsa-spraggs
Educational Activity Learning Objective. Upon com...
Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
by alida-meadow
ACNP Boot Camp 2013. Stephanie Davidson, ACNP-BC....
The Treatment of Sepsis:
The Treatment of Sepsis:
by debby-jeon
Early Goal Directed Therapy. and Beyond. Anthony ...
 Vijay  Aswani   MD, PhD, FACP, FAAP
Vijay Aswani MD, PhD, FACP, FAAP
by faustina-dinatale
Associate Professor of Internal Medicine and Pedi...
Red Flags for Diagnosing MS: Neurologic
Red Flags for Diagnosing MS: Neurologic
by dandy
Abnormal calcification on CT scans. Cerebral venou...
Paolo Spagnolo Clinica di Malattie dell’Apparato Respiratorio
Paolo Spagnolo Clinica di Malattie dell’Apparato Respiratorio
by joanne
Università degli Studi di Padova. Terapia della f...
The n e w e ng l a nd j o u r na l of m e dic i n e n engl j med  www
The n e w e ng l a nd j o u r na l of m e dic i n e n engl j med www
by trish-goza
nejmorg november 29 2007 2277 review article curre...
original article The new england journal of medicine n engl j med  nejm
original article The new england journal of medicine n engl j med nejm
by conchita-marotz
org october 2014 1392 Followup of BloodPressure L...
The n e w e ng l a nd j o u r na l of m e dic i n e n engl j med  www
The n e w e ng l a nd j o u r na l of m e dic i n e n engl j med www
by danika-pritchard
nejmorg november 29 2007 2277 review article curre...
review article The new england journal of medicine n engl j med  www
review article The new england journal of medicine n engl j med www
by stefany-barnette
nejmorg october 2 2003 1360 current concepts Chron...
special article The n e w e ng l a nd j o u r na l of m e dic i n e n engl j med  www
special article The n e w e ng l a nd j o u r na l of m e dic i n e n engl j med www
by giovanna-bartolotta
nejmorg july 26 2007 370 The Spread of Obesity in ...
The new england journal of medicine n engl j med nejm
The new england journal of medicine n engl j med nejm
by calandra-battersby
org original article Outpatient Glycemic Control w...
n engl j med 363;23nejm.orgdecember , 2010PERSPECTIVE
n engl j med 363;23nejm.orgdecember , 2010PERSPECTIVE
by alexa-scheidler
InfluenzaVaccine—Safe,Effective,andMist...
Daclatasvir
Daclatasvir
by giovanna-bartolotta
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
A Prostate Cancer Update: Screening, Over Diagnosis, and Tr
A Prostate Cancer Update: Screening, Over Diagnosis, and Tr
by faustina-dinatale
Matthew D. Katz, M.D.. Assistant Professor. Urolo...
Il  trattamento
Il trattamento
by alida-meadow
del carcinoma . della. . prostata. in . fase. ...
n engl j med www.nejm.orgmay
n engl j med www.nejm.orgmay
by pamella-moone
legal issues in medicine Unspeakably Cruel „...
Boceprevir in Treatment Experienced
Boceprevir in Treatment Experienced
by tatiana-dople
RESPOND-2. Phase . 3. Treatment. . Experienced. ...